Tirz – GIP/GLP-1 Research Peptide

Tirz. (epatide is a synthetic dual agonist peptide with activity at both GIP and GLP-1 receptors, developed for bench-scale research in controlled laboratory settings. This modified peptide has been extensively characterized for receptor binding kinetics, intracellular signaling pathway activation, and metabolic effects in preclinical models.

Research Applications:

• Dual GIP/GLP-1 receptor pharmacology and binding affinity studies
• Incretin signaling pathway characterization and cross-talk mechanisms
• Insulin secretion pathway investigation in pancreatic β-cell models
• Receptor-ligand interaction analysis (EC₅₀/IC₅₀ determination)
• Time-course response studies and signal transduction kinetics
• Stability assessment and analytical method development (HPLC/LC-MS)
• Storage and handling optimization (freeze-thaw, temperature, pH studies)

Specifications:

• Purity: >98% (HPLC verified)
• Molecular Formula: C₂₂₅H₃₄₈N₅₆O₆₈
• Molecular Weight: 4813.5 g/mol
• CAS Number: 2023788-19-2
• Supplied as: Lyophilized powder in sealed vials
• Available doses: 10mg, 20mg, 30mg
• Storage: -20°C, protect from light and moisture
• Each batch includes Certificate of Analysis (COA)

Manufactured under GMP-compliant conditions with rigorous quality control to ensure reproducibility and consistency in laboratory research applications.

For laboratory research use only. Not for human consumption.